(Q48118772)

8 February 2018

title

Evidence for activation of microglia in patients with psychiatric illnesses (English)

1 reference

8 February 2018

0 references

Bayer TA

1

1 reference

8 February 2018

Buslei R

series ordinal

2

1 reference

8 February 2018

Havas L

series ordinal

3

1 reference

8 February 2018

Falkai P

series ordinal

4

1 reference

8 February 2018

language of work or name

English

0 references

publication date

1 August 1999

1 reference

8 February 2018

published in

Neuroscience Letters

1 reference

8 February 2018

volume

271

1 reference

8 February 2018

issue

2

1 reference

8 February 2018

page(s)

126-128

1 reference

8 February 2018

Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900545-5

7 January 2021

Recent advances in defining the neuropathology of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900545-5

7 January 2021

Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900545-5

7 January 2021

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900545-5

7 January 2021

Prefrontal neuropsychological impairment and illness duration in schizophrenia: a study of 204 patients in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900545-5

7 January 2021

No evidence for astrogliosis in brains of schizophrenic patients. A post-mortem study.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900545-5

7 January 2021

Course of schizophrenia: neuropsychological evidence for a static encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900545-5

7 January 2021

Is there cognitive decline in schizophrenia? A cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900545-5

7 January 2021

Heterogeneity of the psychoses: is there a neurodegenerative psychosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900545-5

7 January 2021

Microglia: a sensor for pathological events in the CNS

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900545-5

7 January 2021

Importance of immunological and inflammatory processes in the pathogenesis and therapy of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900545-5

7 January 2021

Reactive astrocytes: cellular and molecular cues to biological function

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900545-5

7 January 2021

Is there gliosis in schizophrenia? Investigation of the temporal lobe

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900545-5

7 January 2021

Gliosis in schizophrenia: a survey

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900545-5

7 January 2021

Dynamics of microglial activation in the spinal cord after cerebral infarction are revealed by expression of MHC class II antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900545-5

7 January 2021

Implications of normal brain development for the pathogenesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900545-5

7 January 2021

Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900545-5

7 January 2021

10.1016/S0304-3940(99)00545-5

Identifiers

DOI

1 reference

8 February 2018

1 reference

8 February 2018